Alphen aan den Rijn, Netherlands

Henri Ernest Boddé

This inventor holds 1 USPTO granted patent. Top assignee: Schwarz Pharma Ag. Active years: 2001.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Henri Ernest Boddé. Retrieved from https://idiyas.com/inventor/henri-ernest-boddandeacute

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2001

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Henri Ernest Boddé: Innovator in Pharmaceutical Compositions

Introduction

Henri Ernest Boddé is a notable inventor based in Alphen A.D. Rijn, Netherlands. He has made significant contributions to the field of pharmaceuticals, particularly in enhancing the permeability of biological membranes.

Latest Patents

Boddé holds a patent for "Pharmaceutical compositions containing 1-oleylazacycloheptan-2-one as enhancing agent of transport across biological membranes." This invention relates to pharmaceutical compositions designed for topical application, which include at least one physiologically active agent and an effective amount of 1-oleylazacycloheptan-2-one. This compound serves as a permeability enhancer for human or animal epithelial membranes, facilitating the application of these compositions through direct contact with the skin or other membranes.

Career Highlights

Boddé is associated with Schwarz Pharma AG, a company known for its innovative pharmaceutical solutions. His work has contributed to advancements in drug delivery systems, particularly in improving the effectiveness of topical medications.

Collaborations

Throughout his career, Boddé has collaborated with esteemed colleagues such as Johanna Aaltje Bouwstra and Maria Helène Ponec. These collaborations have further enriched his research and development efforts in the pharmaceutical domain.

Conclusion

Henri Ernest Boddé's contributions to pharmaceutical compositions highlight his innovative spirit and dedication to enhancing drug delivery methods. His work continues to impact the field positively, paving the way for more effective treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…